Manufacturing Today Issue 212 - May 2023 | Page 138

________________________________________________________________________________________________________________
on extremities and biologics products . With more than 29 years of experience in the medical device industry , David ’ s leadership is integral to Cutera ’ s direction and growth .
His colleague , Rohan Seth , has just as impressive a resumé . His career began in public accounting in Mumbai , where he earned his Master of Business Administration from the University of Notre Dame ’ s Mendoza College of Business and completed his Bachelor of Commerce in Accounting and Auditing from the University of Mumbai ’ s MMK College of Economics and Commerce . He is also a Chartered Accountant from the Institute of Chartered Accountants of India .
As Chief Financial Officer , Rohan brings to Cutera over two decades of finance and business development experience mainly in the medical device industry . Most recently , he served as VP of Finance , Global Orthopaedics Franchise at Smith & Nephew , and before his time there , he served as the Head of Finance , US Surgical at Alcon Labs , where he supported a capital and recurring revenue stream business for nearly four years .
Rohan also spent nine years at Stryker Corporation where he served in various roles across the business , including as Controller of the company ’ s European Division .
Last , but not least , there is Michael Karavitis , Executive Vice President , and Chief Technology Officer . Michael graduated with a Bachelor Studies in Chemistry from Indiana University , and completed his MS and PhD in Chemical and Material Physics at the University of California , Irvine . He is the named inventor in ten US patents , and is the author of 17 publications in peer-reviewed journals . As Chief Technology Officer at Cutera , Michael directs research and development activities ranging from early phase R & D through to product development . Prior to this role , Michael served as Vice President of Research and Development at Cutera from 2012 to 2015 . Under his leadership , Cutera released multiple innovative platforms , as well as product line extensions including Enlighten ( the world ’ s first dual wavelength , dual pulse duration picosecond aesthetic laser ) and Excel HR .
In addition to starting his own company , Femtoblanc Inc ., Michael has led various teams of engineers and scientists at a number of successful companies , including LenSx , which was acquired by Alcon , and Newport Corporation and Intralase Corporation , which were acquired by Advanced Medical Optics .
For Cutera , the goal is simple : define the leading medical aesthetics with devices that appeal to forward-thinking clinicians who need the highest level of performance , safety , and efficacy . Through an array of services , customers can depend on Cutera ’ s skills and engineering . One such innovation offers a solution for acne-prone skin . For Cutera , AviClear is the future of clear skin . This is the first and original FDA-cleared energy device for the treatment of mild , moderate and severe acne on all skin types .
The technology is a laser treatment that offers a safe , prescriptionfree solution for acne . Clinical trials have shown that future breakout
138